DSM, NKT Therapeutics sign contract to develop NKT cells based therapeutics
DSM Biologics provides and develops technologies relevant for optimized mammalian cell culture processes. The contract covers the process development and cGMP manufacturing by DSM of their lead product
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.